← Tillbaka till alla peptider|

Becaplermin

Regenerative
RegenerativeEvidence-based

Becaplermin

Becaplermin dosing, mechanism of action, side effects, and clinical evidence. Complete reference for healthcare professionals.

💉 Topical gel (Regranex)📊 Applied once daily to wound📋 FDA Approved

Last updated: 2026-03-27

🏷️

Category

Regenerative

💉

Route

Topical gel (Regranex)

📊

Dosing

Applied once daily to wound

📋

Evidence

FDA Approved

🏥

Availability

approved

Overview

Becaplermin (Regranex) is a recombinant human platelet-derived growth factor (PDGF-BB) in gel form for treating diabetic neuropathic ulcers.

Mechanism of Action

  • PDGF-BB activity — Stimulates chemotaxis and proliferation of monocytes, neutrophils, and fibroblasts
  • Granulation tissue — Promotes formation of new granulation tissue
  • Wound healing — Accelerates closure of chronic wounds
  • Angiogenesis — Promotes new blood vessel formation in wound bed

Dosing

Applied once daily to wound bed, covered with saline-moistened gauze. Calculate dose based on ulcer size.

Safety

FDA-approved with boxed warning regarding increased risk of cancer mortality with three or more tubes.

Used Becaplermin?

Share your protocol, results, and side effects to help others make informed decisions.

Write a review →